% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{deBoer:273943,
author = {de Boer, Eva M J and de Vries, Bálint S and Van Hecke, Wim
and Mühlebner, Angelika and Vincken, Koen L and Mol,
Christian P and van Rheenen, Wouter and Westeneng, Henk-Jan
and Veldink, Jan H and Höglinger, Günter U and Morris, Huw
R and Litvan, Irene and Raaphorst, Joost and Ticozzi, Nicola
and Corcia, Philippe and Vandenberghe, Wim and Pijnenburg,
Yolande A L and Seelaar, Harro and Ingre, Caroline and Van
Damme, Philip and van den Berg, Leonard H and van de
Warrenburg, Bart P C and van Es, Michael A},
title = {{D}iagnosing primary lateral sclerosis: a
clinico-pathological study.},
journal = {Journal of neurology},
volume = {272},
number = {1},
issn = {0367-004X},
address = {Heidelberg},
publisher = {Springer},
reportid = {DZNE-2024-01417},
pages = {46},
year = {2025},
abstract = {Primary lateral sclerosis (PLS) is a rare motor neuron
disease characterized by upper motor neuron degeneration,
diagnosed clinically due to the absence of a
(neuropathological) gold standard. Post-mortem studies,
particularly TDP-43 pathology analysis, are limited.This
study reports on 5 cases in which the diagnostic criteria
for PLS were met, but in which neuropathology findings
showed (partially) conflicting results. These discrepancies
prompted us to perform a clinico-pathology study focussing
on diagnostic challenges and accuracy in PLS. To this end,
all cases were reviewed by an international panel of 11
experts using an e-module and structured
questionnaires.Autopsy exhibited neuropathological findings
consistent with amyotrophic lateral sclerosis (ALS) in one
case, while two cases exhibited similar, but more limited
lower motor neuron involvement, hinting at PLS or ALS
overlap. Another case displayed tau-pathology indicative of
progressive supranuclear palsy. The final case displayed
extensive myelin loss without a proteinopathy or a clear
diagnosis. The expert panel identified 24 different
ancillary investigations lacking across cases (e.g. genetic
testing, DAT scans, neuropsychological evaluation), listed
28 differential diagnoses, and identified 13 different
conditions as the most likely diagnosis. Autopsy results led
panel members to change their final diagnosis in $42\%$ of
the cases.This study underscores the diagnostic challenges
posed by diverse underlying pathologies resulting in upper
motor neuron phenotypes. Despite adhering to the same
diagnostic criteria, consensus amongst experts was limited.
Ensuring the diagnostic consistency is crucial for advancing
understanding and treatment of PLS. Explicit guidelines for
excluding potential mimics along with a neuropathological
gold standard are imperative.},
keywords = {Humans / Male / Aged / Female / Middle Aged / Motor Neuron
Disease: diagnosis / Motor Neuron Disease: pathology /
Autopsy / Amyotrophic Lateral Sclerosis: diagnosis /
Amyotrophic Lateral Sclerosis: pathology / Amyotrophic
Lateral Sclerosis: genetics / Diagnosis, Differential /
Aged, 80 and over / Brain: pathology / Brain: diagnostic
imaging / DNA-Binding Proteins / Amyotrophic lateral
sclerosis (Other) / Neuropathology (Other) / Primary lateral
sclerosis (Other) / TDP-43 (Other) / Tau (Other) / TARDBP
protein, human (NLM Chemicals) / DNA-Binding Proteins (NLM
Chemicals)},
cin = {Clinical Research (Munich)},
ddc = {610},
cid = {I:(DE-2719)1111015},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39666071},
doi = {10.1007/s00415-024-12816-0},
url = {https://pub.dzne.de/record/273943},
}